Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
Featured
Why AI gets stuck in infinite loops — but conscious minds don’t
Anil Seth suggests the difference is that living beings are rooted in time and entropy, a grounding that may be essential for consciousness.
We purged worms from our bodies — and may have made ourselves sick
Biotech labs are mining worm chemistry to design medicines that calm the immune system without the risks of live infection.
From cryonics to aging: How AI is transforming human health
From curing rare diseases to extending lifespans, four biotech founders share how AI is rewriting the future of medicine.
Psychedelics & Mental Health
Inside a neuroscientist’s quest to cure coma
Thousands of Americans are trapped in disorders of consciousness. Neuroscientist Daniel Toker is searching for a way out.
Pac-Man turned 45 today. The surgeon general once warned that playing it could make kids violent.
Officials’ warnings about the impact of video games on kids were never proven true. They may be making the same mistake with social media.
Flexible brain implant takes major leap forward
The FDA’s clearance of Precision Neuroscience’s flexible electrode array pushes the startup ahead in the race to BCI commercialization.
Biohacking
Three founders look to the future at Freethink’s inaugural Great Progression event
The tech community came together for the launch of the Great Progression event series, curated by Peter Leyden and produced by Freethink.
We’re able to create new creatures through gene editing. What’s stopping us?
The question isn’t whether we can sculpt new life. The question is what comes next.
This conservationist is trying to bring extinct species back to life
Ryan Phelan, co-founder of Revive & Restore, talks about the future of conservation at Freethink’s Great Progression event.
Ray Kurzweil explains how AI makes radical life extension possible
Life expectancy gains in developed countries have slowed in recent decades, but AI may be poised to transform medicine as we know it.
Vaccines
Personalized cancer vaccines are having a moment
Personalized cancer vaccines were a recurring theme at the annual meeting of the American Association for Cancer Research in 2024.
The threat of avian flu — and what we can do to stop it
Avian flu is infecting cows on US dairy farms, and now a person has caught it — but new research could help us avoid a bird flu pandemic.
One shot recreates younger immune systems, in mice
An antibody treatment designed to revitalize an aging immune system delivers “surprising” results in elderly mice.
More
New deep brain stimulator is powered automatically by breathing
A deep brain stimulator powered by breathing could eliminate the need for patients to undergo regular battery-change surgeries.
Brain implant translates neural activity into letters, letting a paralyzed man “speak”
A new device allowed a paralyzed patient to “speak,” spelling out full sentences in real-time with an error rate of about 8%.
Old herpes drug helps kill deadly superbug
The anti-herpes drug edoxudine can weaken the deadly superbug K-pneumoniae, potentially offering a new weapon against antibiotic resistance.
Spinal cord stimulation helps paralyzed patients walk again
Swiss researchers have used epidural electrical stimulation to restore walking in nine people with chronic spinal cord injuries.
Doctors may not be ready for blood tests that screen for multiple cancers at once
MCED tests are different from existing ones because they are trying to detect early-stage cancer, when there aren’t that many tumor cells.
Yale’s new nasal vaccine can boost an mRNA shot
A nasal vaccine delivered as a booster to mRNA shots might offer better protection against COVID-19 and help stop the virus from spreading.
African researchers push for a human challenge trial to fight TB
Tuberculosis kills over a million people a year. Researchers in Malawi are pushing for a clinical trial that may help change that.
Chernobyl fungus could shield astronauts from cosmic radiation
A recent study tested how well the fungi species Cladosporium sphaerospermum blocked cosmic radiation aboard the International Space Station.
Australian man uses brain implant to send texts from his iPad
The Stentrode — a brain-computer interface implanted through minimally invasive surgery — has been used to send text messages from an iPad
A new therapy sends lupus into remission
Five patients in Germany had their lupus wiped out by CAR T-cell therapy.
Engineered bacteria may fight this brain-damaging genetic disorder
A possible phenylketonuria therapy using engineered bacteria has shown positive results in a small phase 2 trial.
A malaria-fighting antibody has passed phase 2 trials
An antibody designed to prevent malaria infection has proven effective in phase 2 trials in Mali.
UK trials world’s first lab-grown blood transfusions
UK researchers have launched the world’s first trial in which lab-grown blood cells are being transfused into another person.
“Laughing gas” may offer quick, long-lasting relief from depression
With ketamine showing potential as an antidepressant, researchers investigate another anesthetic: nitrous oxide, or “laughing gas.”
DNA-damaging molecules in the gut linked to colon cancer
A new Yale study linking a DNA-damaging molecule in the gut to colorectal cancer may give us a way to prevent the deadly disease.
New mRNA vaccine for flu and COVID-19 enters human trials
Pfizer and BioNTech’s new mRNA vaccine designed to protect against COVID-19 and the flu has entered human trials.
New study will put the leading theory about Alzheimer’s to the test
Washington University in St. Louis is embarking on a drug trial that may also put the amyloid hypothesis to its ultimate test.
Organ regeneration could overcome liver failure, without a transplant
Patients wait from 30 days to over five years to receive a liver transplant in the U.S. What if the liver could regenerate itself instead?
“Freakonomics” study offers simple strategy for making tough decisions
People who chose change over inaction, regardless of the decision, self-reported being better off and happier after six months.
AI could help cancer patients avoid a deadly recurrence
A new study found that AI can use a patient’s initial skin cancer growth to predict their risk of melanoma recurrence.
Special Collection
Collection
The Science of Death
Explore the journey from life to death and beyond. Near-death experiences, death doulas, digital immortality, and more – join us for a thoughtful exploration of one life’s most intriguing and inevitable phenomena with stories from the frontlines of death.
Get inspired with the most innovative stories shaping the world around us.